Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Overview

This article presents a method for efficient genome editing of murine hematopoietic stem and progenitor cells (HSPC) using the CRISPR/Cas9 system. The protocol allows for rapid development of mouse models with specific gene modifications in the hematopoietic system.

Key Study Components

Area of Science

• Genetics
• Stem Cell Biology
• Mouse Models

Background

• Genome editing is crucial for studying gene function.
• Hematopoietic stem cells are vital for blood cell development.
• Conventional methods for creating transgenic mice are often time-consuming and costly.
• The CRISPR/Cas9 system offers a more efficient alternative.

Purpose of Study

• To establish a cost-effective method for gene manipulation in hematopoietic stem cells.
• To create mouse models with specific mutations in hematopoietic cells.
• To demonstrate the advantages of using lentivirus-mediated transgene delivery systems.

Methods Used

• Preparation of lentivirus particles using 293T cells.
• Transfection of cells with a mixture of plasmids.
• Collagen coating of plates for cell culture.
• Incubation conditions set at 37 degrees Celsius and 5% carbon dioxide.

Main Results

• Successful establishment of gene-edited mice.
• Demonstrated rapid creation of specific mutations.
• Cost-effective compared to traditional methods.
• Potential for broad applications in hematopoietic research.

Conclusions

• The protocol enhances the efficiency of generating mouse models.
• CRISPR/Cas9 technology is a powerful tool for genetic studies.
• This method can accelerate research in hematopoietic biology.

Frequently Asked Questions